{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:49:31Z","timestamp":1791992971444,"version":"4.4.0"},"reference-count":50,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Natural product (NP) use by patients alongside their conventional cancer therapies is ubiquitous. This common, yet often hidden, practice can potentially contribute to significant patient harm, given the narrow therapeutic window of most anticancer drugs. This review takes on this challenge directly, moving past theoretical concerns to summarize current clinical evidence on interactions between widely used NPs and modern cancer treatments, including chemotherapy, targeted therapy, and immunotherapy. We break down the key pharmacokinetic (PK) mechanisms, such as the disruption of cytochrome P450 enzymes, and the pharmacodynamic (PD) effects that can either help or hinder treatment. By examining both well-established clinical interactions and those supported by preliminary or preclinical findings, we highlight how NPs may alter the effectiveness of anticancer medications and where evidence remains uncertain. Lack of reliable safety information for NPs along with widespread use of these products by patient populations has the potential to impact clinical care and patient outcomes significantly, frequently causing harm. We advocate for improved patient-provider communication and additional evidence-based research to address this gap in literature. The majority of reported interactions are based on preclinical or limited clinical evidence. A more rigorous evidence base including real-world data and clinical trials is urgently needed to guide practice.<\/jats:p>","DOI":"10.3390\/ijms262110494","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:16:24Z","timestamp":1761729384000},"page":"10494","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["When Nature Meets Oncology: Unraveling Herb\u2013Drug Interactions in Cancer Therapy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8508-152X","authenticated-orcid":false,"given":"Ayush","family":"Gandhi","sequence":"first","affiliation":[{"name":"Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samip","family":"Master","sequence":"additional","affiliation":[{"name":"Texas Oncology, Webster, TX 77598, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Bhise","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Berretta, M., Dal Lago, L., Tinazzi, M., Ronchi, A., La Rocca, G., Montella, L., Di Francia, R., Facchini, B.A., Bignucolo, A., and Montopoli, M. (2022). Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity. Cancers, 14.","DOI":"10.3390\/cancers14215203"},{"key":"ref_2","first-page":"e53455","article-title":"The Use of Herbal Medicines Among Cancer Patients","volume":"16","author":"Vasques","year":"2024","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00280-023-04504-z","article-title":"Interactions between natural products and cancer treatments: Underlying mechanisms and clinical importance","volume":"91","author":"Chan","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Samuels, N., and Ben-Arye, E. (2020). Exploring Herbal Medicine Use during Palliative Cancer Care: The Integrative Physician as a Facilitator of Pharmacist\u2013Patient\u2013Oncologist Communication. Pharmaceuticals, 13.","DOI":"10.3390\/ph13120455"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ptr.5213","article-title":"Cancer patients at risk of herb\/food supplement-drug interactions: A systematic review","volume":"28","author":"Alsanad","year":"2014","journal-title":"Phytother. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13020-025-01156-4","article-title":"Herb-drug interactions in oncology: Pharmacodynamic\/pharmacokinetic mechanisms and risk prediction","volume":"20","author":"Duan","year":"2025","journal-title":"Chin. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.325.7362.460\/c","article-title":"St John\u2019s Wort Interferes with Chemotherapy, Study Shows","volume":"325","author":"Josefson","year":"2002","journal-title":"BMJ Br. Med. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/bph.14936","article-title":"Clinical relevance of St. John\u2019s wort drug interactions revisited","volume":"177","author":"Nicolussi","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jphp.12858","article-title":"Understanding drug interactions with St John\u2019s wort (Hypericum perforatum L.): Impact of hyperforin content","volume":"71","author":"Vlachojannis","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"168940","DOI":"10.1155\/2014\/168940","article-title":"Ginseng and anticancer drug combination to improve cancer chemotherapy: A critical review","volume":"2014","author":"Chen","year":"2014","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jnci\/djn148","article-title":"Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?","volume":"100","author":"Lawenda","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1182\/blood-2008-07-171389","article-title":"Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors","volume":"113","author":"Golden","year":"2009","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.19.01203","article-title":"Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients with Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)","volume":"38","author":"Ambrosone","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Liu, Z., Huang, P., Law, S., Tian, H., Leung, W., and Xu, C. (2018). Preventive Effect of Curcumin Against Chemotherapy-Induced Side-Effects. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01374"},{"key":"ref_15","first-page":"1479","article-title":"Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: A URCC CCOP study of 576 patients","volume":"20","author":"Ryan","year":"2012","journal-title":"Support. Care Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/jnci\/djt181","article-title":"Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: A randomized, double-blind trial, N07C2","volume":"105","author":"Barton","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Conti, V., Polcaro, G., De Bellis, E., Donnarumma, D., De Rosa, F., Stefanelli, B., Corbi, G., Sabbatino, F., and Filippelli, A. (2024). Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy. J. Pers. Med., 14.","DOI":"10.3390\/jpm14070685"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11912-023-01408-2","article-title":"Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies","volume":"25","author":"Narayanan","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhou, H., Zhang, M., Cao, H., Du, X., Zhang, X., Wang, J., and Bi, X. (2023). Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs. Pharmaceuticals, 16.","DOI":"10.3390\/ph16121734"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chamberlin, S.R., Blucher, A., Wu, G., Shinto, L., Choonoo, G., Kulesz-Martin, M., and McWeeney, S. (2019). Natural Product Target Network Reveals Potential for Cancer Combination Therapies. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00557"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The Essential Medicinal Chemistry of Curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/94.16.1247","article-title":"Effects of St. John\u2019s wort on irinotecan metabolism","volume":"94","author":"Mathijssen","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fasinu, P.S., and Rapp, G.K. (2019). Herbal Interaction with Chemotherapeutic Drugs-A Focus on Clinically Significant Findings. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01356"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"154247","DOI":"10.1016\/j.phymed.2022.154247","article-title":"Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies","volume":"103","author":"Lam","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/jcrt.JCRT_1017_20","article-title":"The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years","volume":"18","author":"Yerer","year":"2022","journal-title":"J. Cancer Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1478-3231.2012.02864.x","article-title":"Herbal hepatotoxicity: A tabular compilation of reported cases","volume":"32","author":"Teschke","year":"2012","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.106.012047","article-title":"Effects of green tea compounds on irinotecan metabolism","volume":"35","author":"Mirkov","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_28","first-page":"802","article-title":"Dietary supplements and bleeding","volume":"35","author":"Hatfield","year":"2022","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"key":"ref_29","first-page":"146","article-title":"Effect of the Garlic Pill in comparison with Plavix on Platelet Aggregation and Bleeding Time","volume":"2","author":"Fakhar","year":"2012","journal-title":"Iran. J. Ped. Hematol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bcp.12159","article-title":"The effect of Echinacea purpurea on the pharmacokinetics of docetaxel","volume":"76","author":"Goey","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10549-004-4260-x","article-title":"Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh","volume":"90","author":"Rockwell","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_32","first-page":"79","article-title":"Effects of Silybinin on the Pharmacokinetics of Tamoxifen and Its Active Metabolite, 4-Hydroxytamoxifen in Rats","volume":"30","author":"Kim","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00228-007-0396-z","article-title":"The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: Computer-based simulation (SimCYP) predicts in vivo metabolic inhibition","volume":"64","author":"Rakhit","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/jpet.103.055574","article-title":"Interaction of imatinib mesilate with human P-glycoprotein","volume":"307","author":"Hamada","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clpt.2004.06.007","article-title":"Effect of St John\u2019s wort on imatinib mesylate pharmacokinetics","volume":"76","author":"Frye","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0091270009336137","article-title":"Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants","volume":"50","author":"Yin","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1124\/dmd.120.091041","article-title":"Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects","volume":"48","author":"McDonald","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1124\/dmd.30.11.1153","article-title":"Inhibition of human cytochrome P450 activities by kava extract and kavalactones","volume":"30","author":"Mathews","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","article-title":"The flavonoid quercetin in disease prevention and therapy: Facts and fancies","volume":"83","author":"Russo","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Wang, F., Li, G., Xu, J., Zhang, J., Gullen, E., Yang, J., and Wang, J. (2024). From immune checkpoints to therapies: Understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1340307"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Guven, D.C., Sahin, T.K., Rizzo, A., Ricci, A.D., Aksoy, S., and Sahin, K. (2022). The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges. Appl. Sci., 12.","DOI":"10.3390\/app122010548"},{"key":"ref_42","first-page":"206","article-title":"Why bortezomib cannot go with \u2018green\u2019?","volume":"10","author":"Jia","year":"2013","journal-title":"Cancer Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ashin, Z.F., Sadeghi-Mohammadi, S., Vaezi, Z., Najafi, F., AdibAmini, S., Sadeghizadeh, M., and Naderi-Manesh, H. (2024). Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells. BMC Complement. Med. Ther., 24.","DOI":"10.1186\/s12906-024-04631-x"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hussaarts, K.G.A.M., Hurkmans, D.P., Oomen-de Hoop, E., van Harten, L.J., Berghuis, S., van Alphen, R.J., Spierings, L.E.A., van Rossum-Schornagel, Q.C., Vastbinder, M.B., and van Schaik, R.H.N. (2019). Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. Cancers, 11.","DOI":"10.3390\/cancers11030403"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Marx, W., McKavanagh, D., McCarthy, A.L., Bird, R., Ried, K., Chan, A., and Isenring, L. (2015). The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review. PLoS ONE, 10, Erratum in PLoS ONE 2015, 10, e0143675.","DOI":"10.1371\/journal.pone.0143675"},{"key":"ref_46","first-page":"77","article-title":"Adverse event reporting for herbal medicines: A result of market forces","volume":"4","author":"Walji","year":"2009","journal-title":"Healthc. Policy"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Augimeri, G., and Bonofiglio, D. (2021). The Mediterranean Diet as a Source of Natural Compounds: Does It Represent a Protective Choice against Cancer?. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090920"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1056\/NEJMra2211889","article-title":"Diets","volume":"390","author":"Yannakoulia","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e38743","DOI":"10.1097\/MD.0000000000038743","article-title":"Mediterranean diet: Fighting breast cancer naturally: A review","volume":"103","author":"Yao","year":"2024","journal-title":"Medicine"},{"key":"ref_50","first-page":"245","article-title":"American Cancer Society guideline for diet and physical activity for cancer prevention","volume":"70","author":"Rock","year":"2020","journal-title":"CA Cancer J. Clin."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10494\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:18:40Z","timestamp":1761729520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":50,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110494"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110494","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}